Posted in | News

Technique for Characterising Liposome Formulated Drugs

Postnova Analytics has published an application study that describes a new method for quantification of liposome encapsulated drug using Centrifugal Field-Flow Fractionation (CF3).

Nanoparticles including liposomes are increasingly used for delivery of drug molecules. During formulation of a liposome around a drug particle, a relatively large amount of free drug may remain unencapsulated and therefore not available for drug delivery via the liposomal carrier. For formulation groups adopting this drug delivery methodology it is important to quantify the amount of free versus encapsulated drug in a product in order to accurately determine the delivered dose of drug to a patient.

In this study, Centrifugal Field-Flow Fractionation coupled with UV-Vis detection was shown to be able to separate and quantify the amount of free drug in a liposome-drug product. The separation data was verified using optical microscopy. The authors conclude that Centrifugal Field-Flow Fractionation shows great promise for separation and quantification of drug particles, as the field of nanomedicine and liposomal drug delivery grows.

The Postnova CF2000 Series system is based on the CF3 principle using a centrifugal field as driving force for the separation. Particles effected by this field are separated by dynamic diffusion based upon both their size and density. This unique feature allows researchers to separate different particle materials having the same particle size. The separation can be further optimized by the use of different eluents and rotation speed programs. The CF2000 has shown great utility for the separation of complex nanoparticle samples in application areas including pharmaceuticals, environmental research, food, cosmetics and agrochemicals.

To download a copy of this study please visit http://www.postnova.com/application-note/view/50.html. For further information on the CF2000 system please contact Postnova Analytics on +49-8191-985-6880 / +44-1885-475007 / +1-801-521-2004 / [email protected].

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Postnova Analytics. (2018, October 02). Technique for Characterising Liposome Formulated Drugs. AZoM. Retrieved on April 14, 2024 from https://www.azom.com/news.aspx?newsID=49734.

  • MLA

    Postnova Analytics. "Technique for Characterising Liposome Formulated Drugs". AZoM. 14 April 2024. <https://www.azom.com/news.aspx?newsID=49734>.

  • Chicago

    Postnova Analytics. "Technique for Characterising Liposome Formulated Drugs". AZoM. https://www.azom.com/news.aspx?newsID=49734. (accessed April 14, 2024).

  • Harvard

    Postnova Analytics. 2018. Technique for Characterising Liposome Formulated Drugs. AZoM, viewed 14 April 2024, https://www.azom.com/news.aspx?newsID=49734.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.